Study Reports Weight Regain After Stopping GLP-1 Weight Loss Medications

In Brief

A study suggests many users regain weight within a year of stopping GLP-1 obesity drugs.

Key Facts

• A study published in 2024 found that users of GLP-1 weight loss drugs regained about two-thirds of lost weight within one year after stopping treatment, according to The Independent and Sky News
• The study indicated that some individuals may regain weight to levels similar to or higher than before starting the medication, as reported by The Independent
• Weight regain was observed to occur primarily within the first year after cessation of the weight loss injections, based on study findings cited by Sky News
• The research highlights challenges in maintaining weight loss after discontinuing pharmacological treatment, according to the study authors cited in media reports
• The findings were reported by multiple news outlets including The Independent and Sky News in early 2024

What Happened

A study published in 2024 examined weight changes among individuals using GLP-1 receptor agonists, medications used for weight loss. According to media reports, the study found that many users regained a significant portion of the weight lost within one year after stopping the drugs. Some reports noted that weight regain could reach or exceed pre-treatment levels.

Why It Matters

The study's findings, as reported by multiple news sources, suggest that weight loss achieved through GLP-1 medications may not be sustained after discontinuation. This information may be relevant for healthcare providers and patients considering long-term weight management strategies involving these drugs. The exact study details, including sample size and methodology, were not provided in the sources. Reports vary on whether weight regain exceeds pre-treatment weight levels.